Back to News

D&O Trends in 2021: Hard Market, COVID-19 and Other Factors Impacting Life Science Companies

Previously Recorded

Pacific Time
Virtual Event

The range of risk facing executives has increased significantly in recent years, and even before the pandemic, life science companies were more likely to face litigation than other industries. A challenging hard market coupled with heightened risk of lawsuits impact your business in unforeseen ways.  As you prepare for investor meetings during the JP Morgan Healthcare Conference, this panel will discuss the trends that will have significant risk implications for senior management in 2021 and beyond.

Cooley partners Koji Fukumura and Kristin VanderPas will speak at this event.

Topics include

  • SPAC landscape
  • Covid impacts
  • Federal forum provisions
  • Shareholder litigation
  • Officer liability
  • Diversity requirements

View on-demand recording

For more information, please email Deborah Argueta.

Related Contacts
Koji Fukumura  Partner San Diego
Kristin VanderPas  Partner San Francisco